'DELENDASES®' (F3B3R/X44NM/PLL77)

Link to article: 'DELENDASES®' (F3B3R/X44NM/PLL77).


@import url('https://fonts.googleapis.com/css2?family=Charm:wght@400;700&display=swap');
@import url('https://fonts.googleapis.com/css2?family=Courier+Prime:ital,wght@0,400;0,700;1,400;1,700&display=swap');
@import url('https://fonts.googleapis.com/css2?family=Open+Sans:ital,wght@0,300..800;1,300..800&display=swap');

.page {
    display: block;
    transform: rotate(1.2deg);
    overflow: hidden;
    font-family: "Charm", sans-serif;
    font-style: normal;
    font-size: 15px;
    line-height: 1.2;
    box-shadow: 0px 0px 7px;
    background-attachment: scroll;
    background-clip: border-box;
    background-color: white;
    background-image: linear-gradient(to top ,rgb(255, 255, 255) 45%, rgb(255, 255, 255) 8%);
    background-origin: padding-box;
    background-position: 0px 8px;
    background-repeat: repeat;
    background-size: 100% 20px;
    border: 1px solid #CCC;
    padding: 10px 10px;
    margin-bottom: 10px;
    box-shadow: 0px 1px 3px rgba(0, 0, 0, 0.2)
}
.page p,
.page ul {
    line-height: 20px;
    margin: 0;
}
.email {border: solid 2px #000000; width: 88%; padding: 1px 15px; margin: auto; box-shadow: 0 1px 3px rgba(0,0,0,.5); background-color: white; color: black; font-family: "Helvetica";}
.email-example a.collapsible-block-link {font-weight: bold;}
.tofrom {margin-left: 10px; margin-top: 5px; padding: 1px 15px; border-left: solid 3px royalblue;font-family: "Helvetica"}
.tofrom2 {margin-left: 10px; margin-top: 5px; padding: 1px 15px; border-left: solid 3px royalblue; font-family: "Helvetica"}

a, a.newpage, a:visited, #interwiki a, #side-bar a {
    color: royalblue;
}

.zillow {
  border: solid 2px royalblue;
  width: 75%;
  padding: 1px 15px;
  margin: auto;
  background-color: white;
  color: black;
  font-family: "Open Sans";
}

.court-document {
display: grid;
border: 2px solid black;
width: fit-content;
counter-reset: lineno;
grid-template-columns: repeat(2, auto);
overflow: hidden;
background-color: #ebdaf3;
color: black;
}

.num::before {
content: counter(lineno);
counter-increment: lineno;
}

.monospace {
font-family: 'Andale Mono', 'Courier New', Courier, monospace;
line-height: 1;
padding: 10px;
font-size: 16px;
}

.monospace p {
margin: 1lh 0;
line-height: 1;
}

.lineno-container {
height: 0;
}

.linenos {
border-right: 1px solid black;
}

.nums::after {
content: "1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857";
width: 0;
display: block;
overflow-wrap: initial;
margin-right: 2em;
}

.court-document-content {
margin-bottom: -1.5lh;
}

.invisible{
   color:transparent;
}

.imagebox {
    position: relative;
    padding: 0.2em;
    margin: 0.2em;
    box-shadow: 2px 1.5px 1px lightgrey, 0 0 0px 1px lightgrey;
    overflow-wrap: break-word;
}

```
float: center
```

```
email
```
```
tofrom
```
```
email
```
```
tofrom
```
```
ff-article
```
```
ff-title
```
```
ff-subtitle
```
```
email
```
```
tofrom
```
```
email
```
```
tofrom
```

=====
[[include component:preview
text= Our products combine the magic feared by Roman emperors with the science of the future; there is no room for error or omission.
]]
=====


[[include :scp-wiki:theme:black-diamond]]
[[include :scp-wiki:component:text-style]]
[[include :jyj:ff]]

[[module CSS]]

@import url('https://fonts.googleapis.com/css2?family=Charm:wght@400;700&display=swap');
@import url('https://fonts.googleapis.com/css2?family=Courier+Prime:ital,wght@0,400;0,700;1,400;1,700&display=swap');
@import url('https://fonts.googleapis.com/css2?family=Open+Sans:ital,wght@0,300..800;1,300..800&display=swap');

.page {
    display: block;
    transform: rotate(1.2deg);
    overflow: hidden;
    font-family: "Charm", sans-serif;
    font-style: normal;
    font-size: 15px;
    line-height: 1.2;
    box-shadow: 0px 0px 7px;
    background-attachment: scroll;
    background-clip: border-box;
    background-color: white;
    background-image: linear-gradient(to top ,rgb(255, 255, 255) 45%, rgb(255, 255, 255) 8%);
    background-origin: padding-box;
    background-position: 0px 8px;
    background-repeat: repeat;
    background-size: 100% 20px;
    border: 1px solid #CCC;
    padding: 10px 10px;
    margin-bottom: 10px;
    box-shadow: 0px 1px 3px rgba(0, 0, 0, 0.2)
}
.page p,
.page ul {
    line-height: 20px;
    margin: 0;
}
.email {border: solid 2px #000000; width: 88%; padding: 1px 15px; margin: auto; box-shadow: 0 1px 3px rgba(0,0,0,.5); background-color: white; color: black; font-family: "Helvetica";}
.email-example a.collapsible-block-link {font-weight: bold;}
.tofrom {margin-left: 10px; margin-top: 5px; padding: 1px 15px; border-left: solid 3px royalblue;font-family: "Helvetica"}
.tofrom2 {margin-left: 10px; margin-top: 5px; padding: 1px 15px; border-left: solid 3px royalblue; font-family: "Helvetica"}

a, a.newpage, a:visited, #interwiki a, #side-bar a {
    color: royalblue;
}

.zillow {
  border: solid 2px royalblue;
  width: 75%;
  padding: 1px 15px;
  margin: auto;
  background-color: white;
  color: black;
  font-family: "Open Sans";
}

.court-document {
display: grid;
border: 2px solid black;
width: fit-content;
counter-reset: lineno;
grid-template-columns: repeat(2, auto);
overflow: hidden;
background-color: #ebdaf3;
color: black;
}

.num::before {
content: counter(lineno);
counter-increment: lineno;
}

.monospace {
font-family: 'Andale Mono', 'Courier New', Courier, monospace;
line-height: 1;
padding: 10px;
font-size: 16px;
}

.monospace p {
margin: 1lh 0;
line-height: 1;
}

.lineno-container {
height: 0;
}

.linenos {
border-right: 1px solid black;
}

.nums::after {
content: "1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857";
width: 0;
display: block;
overflow-wrap: initial;
margin-right: 2em;
}

.court-document-content {
margin-bottom: -1.5lh;
}

.invisible{
   color:transparent;
}

[[/module]]

[[>]]
[[module rate]]
[[/>]]

[[include :scp-wiki:component:author-label-source start=--
|name=Heck_Tech]]
DELENDASES® (F3B3R/X44NM/PLL77) by [[*user Heck_Tech]]
[[include :scp-wiki:component:author-label-source end=--]]



||||~ F3B3R/X44NM/PLL77||
||~ Status||Selling/Acquirable||
||~ Demand||High||
||~ Value||1,200,000USD/1,000,000GBP per Box, 120,000,000USD/100,000,000GBP per Crate||
||~ Availability||Established Supply Chain||
||~ External Partners || Febris Pharmaceuticals S.p.A. ||
||~ Revenue Split || 80% in favor, 20% to external partner(s) ||
||~ Identifier|| DELENDASES® ||
||~ Description|| Items are 15mg tablets containing thaumatologically modified enzymes. Ingestion causes body dissolution within a few minutes, leaving a neglectible dust residual. Sold in boxes of 12, available from supplier in crates of 100.||
||||~ Marshall, Carter and Dark, Ltd.||

@@ @@
@@ @@


[[div class="email"]]
[[div class="tofrom"]]
**To:** ##9538a5|percivaldarke@mcd_intmail.mcd##
**From:** ##9538a5|ruprechtcarter@mcd_intmail.mcd##
**Date Sent:** 10/05/2008 21:54 GMT
**Subject:** Report
[[/div]]
Percival, 

I inform you that the situation in [[[https://scp-wiki.wikidot.com/locations-of-interest#goricna | Gorična]]] has reached a critical point.

The revolt has inflamed every District of the city. Everywhere I turn, there are marches of hundreds and hundreds of people waving banners and raising weapons against the few remaining law enforcement officers.

Our candidate for the Council of Six has already left the city, and the latest news is that he's taking refuge in a hotel in Trieste. Those stupid idiots in charge have decided not to receive me and have shrugged their shoulders; they firmly believe that covering their eyes and ears and giving free rein to these packs of beasts is the best way to avoid being hung by their ankles in the Market Square.

Our commercial activities are interrupted: the city's port is under siege, our cargo ships can't even get close to the docks, and our warehouses are being reduced to ashes despite the eternal rain of this cursed place.

It won't be long before the uprising reaches headquarters, and worse still, it opens the door for the Foundation and other scum to exploit this Carnival to steal our products and data.

I still can't believe that the main gateway to the Southern European market on both sides of the Veil could be about to be taken away from us by a bunch of thugs.

However, there are some ways to mitigate the damage. 

I've been contacted by representatives of companies in the surrounding areas; don't be fooled, as you might have guessed, they're mostly cutthroats boasting dreams of glory, drawn by the smell of blood. But there's one name who particularly stands out from the crowd.

It's not a well-known company, and it's already had some issues with the Foundation, from what I've been told, but given the gravity of the situation, I think it would be foolish to refuse a business proposition out of hand. Given how the situation is worsening by the minute, I'll forward your contact information directly to the CEO so he can communicate his offer to you.

I'm attaching all the details about him and his company that our employees who haven't yet fled have recovered.

Yours,
Ruprecht Sidereal Carter
[[/div]]

@@ @@
@@ @@

[[div class="email"]]
[[div class="tofrom"]]
**To:** ##9538a5|percivaldarke@mcd_outmail.mcd##
**From:** ##9538a5|faustofarnesi@ufficio_febrisfarmaceutica.it##
**Date Sent:** 12/05/2008 08:00 GMT
**Subject:** Product Presentation
[[/div]]
Dear Sir Darke,

I introduce this mail by emphasizing how honored I am by the attention and opportunity you have granted to my company, especially in light of these turbulent times that needlessly take away time from those who have the power to grant it.

As a businessman, albeit in a currently modest market limited to a single nation, I understand the importance of appearances: the man who wrote that there is no such thing as bad publicity was certainly unaware of the causes and consequences of Free Port revolts on the transfer of capital.

Therefore, as already discussed in person with sir Carter, [[[http://scp-int.wikidot.com/gruppi-di-interesse#FF | my company]]] is ready to succeed to Gorična as your company's vassal in order to prevent the access to the Southern European market from being interrupted. Men are fickle, ready to topple crowns and overthrow thrones in the name of freedom, but offer them the illusion of control over their fate and the resulting prosperity, and their spirits weaken, and the new "Friend of the people" is ready to dominate them with smiles and benevolence.

A hospital, a new wing for the public library, and the supposed freedom from the control of a harsh master: my company is ready to offer all this in exchange for access to the market you represent, guaranteeing the passage of your cargo through the most important port in the Adriatic Sea on the other side of the Veil, not yet subjugated by our common enemies.

As proof of my loyalty to the cause, I present to you a product that can demonstrate the potential of my company for the needs that men of your caliber and nobility may ever encounter.

Yours faithfully,
[[<]]
Dr. Fausto Farnesi MD
CEO of Febris Farmaceutica
[[/<]]
[[/div]]

@@ @@
@@ @@

[[div class="ff-article"]]
[[=]]
[[span class="ff-title"]]

**FEBRIS PHARMACEUTICALS** 


[[module CSS]]
.imagebox {
    position: relative;
    padding: 0.2em;
    margin: 0.2em;
    box-shadow: 2px 1.5px 1px lightgrey, 0 0 0px 1px lightgrey;
    overflow-wrap: break-word;
}
[[/module]]

 [[image https://i.postimg.cc/JzRQHgQF/Polish-20250929-172402503.webp  width="100" style="float: center"]]



//"Nostrum malum, nostra salus"// 
[[/span]]

[[span class="ff-subtitle"]]
**DELENDASES® 15mg**
[[/span]]
[[/=]]


__**1.1 Product identifier:**__ 

Delendases®

__**1.2 Specific uses of the substance:**__

General induction of apoptotic  process[[footnote]]**Note for buyers:** Apoptosis is a controlled cell suicide process induced in case of severe cellular stress or damage, which can compromise the cell's replicative capacity and promote carcinogenesis.[[/footnote]].

__**1.3 Classification of the substance:**__

H300 - Fatal if swallowed.
H318 - Causes serious eye damage.
H370 - Causes damage to all organs if swallowed or inhaled.

__**1.4 Other Dangers/Indications:**__

In its solid state, Delendases® is physically inert and can withstand temperatures between 5 and 30 degrees Celsius. 

Avoid exposing the product to humid environments before use to ensure maximum effectiveness.

Exposure to the compound is not teratogenic.

Use in pregnant women is not recommended at the lowest dose.


__**2.1 Composition (% w/w):**__

* Delendases® (80)
* Adjuvants (20)


__**2.2 Description of properties:**__

Delendases® is a thaumatologically modified enzyme (TME) whose purpose is to induce the apoptotic process in every cell composing the tissues and the organs of the human body.

For use in the human body, it is produced and sold as a 15 mg spherical pill, corresponding to the minimum dose necessary to activate the effects of the active ingredient.

Lower doses can be used for subjects under 45kg and under 12 years of age by using a part of the pill, but below 10mg, the effectiveness of the active ingredient is not guaranteed.

The pill can be dissolved in a glass of water or another liquid, but for effective and complete results it must be consumed within 5 minutes.

When ingested, the hydrochloric acid in gastric juices activates adjuvant substances to accelerate intestinal absorption and transport to all tissues. Once it crosses the cell membrane, the enzyme is able to induce the apoptotic process in the cytoplasm by inducing the formation of the apoptosome and the induction of the caspase enzyme cascade.

This normal and common process of cellular metabolism is then replicated by any cell adjacent to the cell receiving the enzyme, causing a rapid general dissolution of the organism.

Within 3 to 5 minutes of ingestion, depending on the individual's bone composition and fat mass, the subject's body will be completely dissolved, generating only an almost imperceptible amount of solid residue and gas as waste.


__**2.3 First aid measures:**__

In case of accidental ingestion, it is essential to induce vomiting within the first 30 seconds and contact your doctor or thaumaturgist.

The product cannot produce its effects upon contact with skin, but it is highly recommended to rinse the affected areas thoroughly.

@@ @@
[[=]]
Febris Farmaceutica S.p.A. - Florence, IT
[[/=]]
[[/div]]

@@ @@
@@ @@

[[div class="email"]]
[[div class="tofrom"]]
**To:** ##9538a5|faustofarnesi@ufficio_febrisfarmaceutica.it## 
**From:** ##9538a5|percivaldarke@mcd_outmail.mcd##
**Date Sent:** 12/05/2008 09:30 GMT
**Subject:** Re: Product Presentation
[[/div]]

Dear Dr. Farnesi,

Your words certainly do not lack the resoluteness you could have shown in your brief conversation with my partner, but faced with a request that would undoubtedly prove far more advantageous for you and your small company, I still have a slight doubt to share.

Although scant, the informations about your lineage and the vocation of your business activities, aimed at benefiting your mother, are certainly not secret. How, then, can the CEO of such a enterprise speak to me of alliances, "vassalage," and loyalty?

As the child of a forgotten deity, I assumed you would know the value of making someone believe something.

Best regards,
[[<]]
Sir Percival Atherolis Darke
Founder and CEO of MC&D Ltd
[[/<]]
[[/div]]

@@ @@
@@ @@

[[div class="email"]]
[[div class="tofrom"]]
**To:** ##9538a5|percivaldarke@mcd_outmail.mcd##
**From:** ##9538a5|faustofarnesi@ufficio_febrisfarmaceutica.it##
**Date Sent:** 12/05/2008 10:00 GMT
**Subject:** Re: Re: Product Presentation
[[/div]]
Dear Sir Darke,

I am deeply saddened that my proposal may have offended you by the sincerity of my intentions.

If you agree to try our product, you will understand that, despite the initial lack of resources, Febris Pharmaceuticals is a serious company, [[[https://scp-wiki.wikidot.com/dado-hub | unlike dubious, highly unreliable and unqualified individuals]]] that have given the parachemical market a reputation for ineffectiveness and danger.

Our products combine the magic feared by Roman emperors with the science of the future; there is no room for error or omission.

And if my origins and the mission that guides my company may seem like a conflict of interest, I can assure you that none of this will interfere with the nature of our business. As you know, what we produce is a prayer to a goddess whose lineage I can claim, so our intent is to maximize the scope of our activities according to the laws of the market. 

Whether pharmaceuticals or other goods, production and sales are fundamental to us, and this is where our loyalty to a company like Marshall, Carter & Dark lies. We would in no way hinder those whose support allows us to do this, and we are equally confident in preventing it from happening, whether the threat is internal or external.

You may still think all this is only beneficial to me, my company, or the deity who created me, but that doesn't change the fact that from one day to the next, Gorična will be out of your reach and directly into the dirty hands of some vulgar and mediocre cocaine-dealing gangster, or worse yet, into the complete custody of the Foundation. 

Goodbye Gorična, goodbye Southern Europe, goodbye Mediterranean.

An economic resource like few others that will be permanently sealed off from any other real business man who knows how to make a real profit from it, and this, only because there was no one trustworthy to manage the situation.

Therefore, Sir Darke, I ask you again to consider my proposal and accept the Febris Pharmaceuticals product I initially wanted to offer you, a symbol of our business and our methods. 

Mei fidem virtutemque experere[[footnote]]Test my loyalty and my worth.[[/footnote]] .


Yours faithfully,
[[<]]
Dr. Fausto Farnesi MD
CEO of Febris Farmaceutica
[[/<]]
[[/div]]



@@ @@
@@ @@


||||~ Initial Writeup||||
||~ Penned by: || Percival Atherolis Darke ||
||~ Date || May 21, 2008||
||~ Interest||High||
||~ Identifier||DELENDASES®||
|||| The Item description was attached to the first email sent by Dr Farnesi prior to sending the first shipment of the product to the London headquarters warehouses. _
 _
Despite initial doubts, the product is indeed as effective as reported in the paper. The amount of residual dust is quite negligible. Indeed, it has the potential to be a top product for the 2008/2009 fiscal year. _
 _
New shipments of the product are expected in the next weeks from our new business partner.||
||~ File Opened Under:||||  F3B3R/X44NM/PLL77||
||||~ Marshall, Carter & Dark Ltd.||

@@ @@
@@ @@


||||||~ Sale Records||
||||||~ F3B3R/X44NM/PLL77  ||
||~ Records From:||||May, 2008 to December, 2008||
||~ Listing |||||| Drawing on the latest research in parabiotechnology and parapharmacology, we offer a product that addresses a need that businesspeople may unfortunately encounter during negotiations: the removal of the remains of their obstacle, the primary source of unwanted attention that can lead to equally undesirable consequences. DELENDASES® is the product that solves this age-old problem, eliminating the need for acids, plastic bags, shovels, and burial sites, providing complete, investigation-proof elimination. //Marshall, Carter and Dark Ltd. takes no responsibility for the misuse of this item.// ||
||~ Month ||~ Sold ||~ Comments||
|| May, 2008 || 30 || ||
|| June, 2008 || 550 || A spike in sales after the Dellinger affair. ||
|| July, 2008 || 651 ||  ||
|| August, 2008 || 733 || ||
|| September, 2008 || 680 ||  ||
|| October, 2008 || 677 || The sales rate seems to have stabilized at an average considered satisfactory for this type of product. ||
|| November, 2008 || 850 || A spike in sales caused by the unexpected post-Valentine's Day surprises being thrown away before there are two pills to use. ||
|| December, 2008 || 702||  ||
||||||||~ Marshall, Carter & Dark, Ltd.||

@@ @@
@@ @@

[[image https://scp-wiki.wdfiles.com/local--files/delendases-f3b3r-x44nm-pll77/Dellinger-Newspaper.jpg]]

@@ @@
@@ @@

[[image https://scp-wiki.wdfiles.com/local--files/delendases-f3b3r-x44nm-pll77/Gori-Newspaper.jpg]]

@@ @@
@@ @@

[[include :scp-wiki:component:license-box]]

> **Filename:** Dellinger Newspaper
> **Author:** [[*user Heck_Tech]]
> **License:** CC BY-SA 3.0
> **Source Link:** https://scp-wiki.wdfiles.com/local--files/delendases-f3b3r-x44nm-pll77/Dellinger-Newspaper.jpg

> **Filename:** Gori Newspaper
> **Author:** [[*user Heck_Tech]]
> **License:** CC BY-SA 3.0
> **Source Link:** https://scp-wiki.wdfiles.com/local--files/delendases-f3b3r-x44nm-pll77/Gori-Newspaper.jpg

[[include :scp-wiki:component:license-box-end]]

'DELENDASES®' (F3B3R/X44NM/PLL77)

Module Styles

Inline Styles

Includes

CSS Classes

Page Source